urea has been researched along with Extramembranous Glomerulopathy in 6 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We compare the change in serum Cystain C (CysC), urea, creatinine (CREA), uric acid (UA), total protein (TP), albumin (ALB), IgG4 and 24-h urinary protein (proteinuria, PRO) between PLA2RAb+ and PLA2RAb- of IMN patients." | 3.81 | Comparison of biomarkers between PLA2RAb+ and PLA2RAb- in patients with idiopathic membranous nephropathy. ( Jiang, Y; shuai, L; Wang, W; Xun, C, 2015) |
| " Rosiglitazone limited the development of proteinuria and prevented plasma urea elevation (8." | 3.74 | Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing. ( den Ouden, K; Goldschmeding, R; Joles, JA; Nguyen, TQ; Verhaar, MC; Westerweel, PE, 2008) |
| " The outcome of the disease was on 5 ways: I (17 patients)-long remission without proteinuria or with a presence of non-nephrotic proteinuria, II (11 patients)-relapsing disease, III (22 patients)-persistent nephrotic syndrome with slow progressive renal failure, IV (3 patients) rapid development of chronic renal failure and V (5 cases) remission after long period of occurrence of nephrotic syndrome and elevated serum levels of urea and creatinine." | 3.69 | [Membranous glomerulonephritis]. ( Polenaković, M, 1996) |
| "To find new diagnostic markers for idiopathic membranous nephropathy (IMN) and also conduct preliminary explorations into the possible pathogenesis of IMN by comparing the expression of microRNA-451a (miR-451a), miR-106a, miR-19b, miR-17, and phosphatase and tensin homolog (PTEN) protein in the serum of patients with IMN and healthy controls." | 1.62 | Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy. ( Li, X; Liu, Y; Luo, L; Qin, X; Wu, L; Zhang, X, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 2 |
| Luo, L | 2 |
| Zhou, L | 1 |
| Li, N | 1 |
| Qin, X | 2 |
| Zhang, X | 1 |
| Li, X | 1 |
| Liu, Y | 1 |
| Xun, C | 1 |
| shuai, L | 1 |
| Wang, W | 1 |
| Jiang, Y | 1 |
| Westerweel, PE | 1 |
| den Ouden, K | 1 |
| Nguyen, TQ | 1 |
| Goldschmeding, R | 1 |
| Joles, JA | 1 |
| Verhaar, MC | 1 |
| Cattran, DC | 1 |
| Greenwood, C | 1 |
| Ritchie, S | 1 |
| Bernstein, K | 1 |
| Churchill, DN | 1 |
| Clark, WF | 1 |
| Morrin, PA | 1 |
| Lavoie, S | 1 |
| Polenaković, M | 1 |
1 trial available for urea and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group.
Topics: Adult; Aged; Creatinine; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Hu | 1995 |
5 other studies available for urea and Extramembranous Glomerulopathy
| Article | Year |
|---|---|
GDF-15 and sST-2 act as biomarkers of disease severity but not independent predictors in idiopathic membranous nephropathy.
Topics: Autoantibodies; Biomarkers; Glomerulonephritis, Membranous; Humans; Receptors, Phospholipase A2; Sev | 2022 |
Altered expression of serum miR-106a, miR-19b, miR-17, and PTEN in patients with idiopathic membranous nephropathy.
Topics: Albumins; Case-Control Studies; Creatinine; Cystatin C; Female; Gene Expression Regulation; Glomerul | 2021 |
Comparison of biomarkers between PLA2RAb+ and PLA2RAb- in patients with idiopathic membranous nephropathy.
Topics: Adult; Antibodies; Biomarkers; Creatinine; Cystatin C; Female; Glomerulonephritis, Membranous; Human | 2015 |
Amelioration of anti-Thy1-glomerulonephritis by PPAR-gamma agonism without increase of endothelial progenitor cell homing.
Topics: Aneurysm; Animals; Blood Pressure; Bone Marrow Transplantation; Cell Movement; Disease Models, Anima | 2008 |
[Membranous glomerulonephritis].
Topics: Adolescent; Adult; Aged; Creatinine; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Huma | 1996 |